Evidence map›Paper›PMID 23851597›Full record

ArticlePrion

Prion protein and susceptibility to kainate-induced seizures: genetic pitfalls in the use of PrP knockout mice.

James F Striebel, Brent Race, Bruce Chesebro

Open access · bronzeAbstract readComment
In one paragraph

Article in Prion. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Physiological Functions of the Cellular Prion Protein.Frontiers in molecular biosciences · 2017
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

James F StriebelLaboratory of Persistent Viral Diseases; Rocky Mountain Laboratories; National Institute of Allergy and Infectious Diseases; Hamilton, MO USA.
Brent Race
Bruce Chesebro
Global Viral · USNational Institute of Allergy and Infectious Diseases · US

Funding

Biology of Prion Protein and the TSE DiseasesZIAAI000937 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI CHESEBRO, BRUCE · 2009 to 2025
$16.9M
6 · The paper itself

Abstract

Prion protein (PrP) is a cell surface glycoprotein which is required for susceptibility to prion infection and disease. However, PrP is expressed in many different cell types located in numerous organs. Therefore, in addition to its role in prion diseases, PrP may have a large variety of other biological functions involving the nervous system and other systems. We recently showed that susceptibility to kainate-induced seizures differed in Prnp(-/-) and Prnp(+/+) mice on the C57BL/10SnJ background. However, in a genetic complementation experiment a PrP expressing transgene was not able to rescue the Prnp(+/+) phenotype. Thus the apparent effect of PrP on seizures was actually due to genes flanking the Prnp(-/-) gene rather that the Prnp deletion itself. We discuss here several pitfalls in the use of Prnp(-/-) genotypes expressed in various mouse genetic backgrounds to determine the functions of PrP. In particular, the use of Prnp(-/-) mice with heterogeneous mixed genetic backgrounds may have weakened the conclusions of many previous experiments. Use of either co-isogenic mice or congenic mice with more homogeneous genetic backgrounds is now feasible. For congenic mice, the potential problem of flanking genes can be mitigated by the use of appropriate transgene rescue experiments to confirm the conclusions.

Indexed as

Gene ExpressionAnimalsNeuronsPrionsSeizuresPrionsflanking geneskainatePrnp deletionPrnp knockoutseizures

Identifiers

PMID23851597
PMCPMC3904312
OpenAlexW2005364854

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.